Motexafin Gadolinium (MGd) is Active as a Single Agent and in Combination with Pemetrexed and Docetaxel in Advanced Non–Small-Cell Lung Cancer (NSCLC) Patients who Failed Platinum-Based Chemotherapy: Early Results of 3 Phase II Trials

Autor: Natale, R.B., Nicholas, G., Pandya, K., Edelman, M., Phan, S.C., Renschler, M.F.
Zdroj: In Clinical Lung Cancer July 2007 8(7):455-455
Databáze: ScienceDirect
Externí odkaz: